Document is current

Any future updates will be listed below

Impact of Pertuzumab and Ado-Trastuzumab Emtansine on Cumulative Avoidance of Recurrence Among Women Treated for Locally Advanced, Inflammatory, or Early-Stage Nonmetastatic HER2-Positive Breast Cancer in the United States

Crossref DOI link: https://doi.org/10.1007/s12325-023-02554-6

Published Online: 2023-06-26

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark